PharmaCyte Biotech Inc (PMCB)

[1234jklm]

Big picture

They’re in the final stages of completing the ind submission material for a technology that will offer an unprecedented surgical precision to chemotherapy on cancerous tumors, without side effects, to make inoperable tumors operable.

If they’re making the process of manufacturing the cells better that’s a good thing.

They are closer than they’ve ever been before.

The manufacturing system is being optimised to be better than ever before.

That does not equate to them encountering a problem or a delay.

It just means they’re getting closer to making this a success with the actual cells they’ll be using in the trial which are slightly different from previous cells they’ve worked with . And it sounds like they’re making the technology and processing even better.

That’s the process of creative innovation.

Isn’t that great?

Any other conclusion is based on fear and anxiety.